跳至主要内容
临床试验/NL-OMON42012
NL-OMON42012已完成不适用

Inhalation or nasal corticosteroids and prevalence of hypothalamic-pituitary-adrenal axis suppression in HIV-infected patients - incorporate

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Receive a treatment for HIV-infection
  • - > 18 years old
  • - Current usage of inhalation or nasal corticosteroids
  • - Willing to give informed consent

排除标准

  • - Known adrenal insufficiency
  • - Concurrent use of topical corticosteroids, usage of oral corticosteroids in the last three months. Intramuscular or intra-articular corticosteroid injections in the last year.
  • - Contra-indications for tetracosactide: allergy for tetracosactide, Cushings*s syndrome, refractory heart failure, peptic ulcer, acute psychosis, adrenogenital syndrome
  • - Pregnant female or breast-feeding female.
  • - Use of oral contraceptives, since these can heighten the cortisol-binding globulin

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验

Inhalation or nasal corticosteroids and prevalence... | 临床试验